MetaADEDB 2.0 @ LMMD
Mirtazapine
(RONZAEMNMFQXRA-UHFFFAOYSA-N)
Structure
SMILES
CN1CCN2C(C1)c1ccccc1Cc1c2nccc1
Type(s)
Approved
ATC code(s)
N06AX11
Molecular Formula:
C17H19N3
Molecular Weight:
265.353
Log P:
2.4818
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
0
TPSA:
19.37
CAS Number(s):
61337-67-5; 85650-52-8
Synonym(s)
1.
Mirtazapine
2.
(N-Methyl-11C)mirtazapine
3.
(S)-Mirtazapine
4.
6-Azamianserin
5.
Esmirtazapine
6.
Norset
7.
ORG 3770
8.
ORG-3770
9.
Org 50081
10.
Remergil
11.
Remeron
12.
Rexer
13.
Zispin
14.
6 Azamianserin
15.
ORG3770
External Link(s)
MeSHD000078785
PubChem Compound4205
BindingDB50115644
ChEBI6950
CHEMBLCHEMBL654
DrugBankDB00370
DrugCentral1816
IUPHAR/BPS Guide to PHARMACOLOGY7241
KEGGcpd:C07570
dr:D00563
Therapeutic Target DatabaseD05ZIK
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AnxietyFAERS: 149
Canada Vigilance: 16
Canada Vigilance
OFFSIDES
SIDER
US FAERS
2Drug ineffectiveFAERS: 128
Canada Vigilance: 22
Canada Vigilance
US FAERS
3DizzinessFAERS: 124
Canada Vigilance: 14
Canada Vigilance
SIDER
US FAERS
4Completed SuicideFAERS: 116
Canada Vigilance: 5
Canada Vigilance
OFFSIDES
US FAERS
5SomnolenceFAERS: 105
Canada Vigilance: 18
Canada Vigilance
SIDER
US FAERS
6AgitationFAERS: 104
Canada Vigilance: 13
Canada Vigilance
SIDER
US FAERS
7HeadacheFAERS: 103
Canada Vigilance: 6
16096515CTD
SIDER
Canada Vigilance
US FAERS
8FatigueFAERS: 95
Canada Vigilance: 7
12702891CTD
SIDER
Canada Vigilance
US FAERS
9OverdoseFAERS: 95
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
10NauseaFAERS: 92
Canada Vigilance: 9
16096515CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
11AngerFAERS: 87
Canada Vigilance: 6
Canada Vigilance
OFFSIDES
US FAERS
12TremorFAERS: 85
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
13MalaiseFAERS: 77
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
14ArthralgiaFAERS: 64
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
15Feeling abnormalFAERS: 64
Canada Vigilance: 8
Canada Vigilance
SIDER
US FAERS
16Restless Legs SyndromeFAERS: 64
Canada Vigilance: 3

View details

CTD
SIDER
Canada Vigilance
US FAERS
17MyalgiaFAERS: 61
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
18Suicide attemptFAERS: 60
Canada Vigilance: 2
Canada Vigilance
US FAERS
19AstheniaFAERS: 53
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
SIDER
US FAERS
20Pharmaceutical product complaintFAERS: 50US FAERS
21VomitingFAERS: 50
Canada Vigilance: 3
16096515CTD
SIDER
Canada Vigilance
US FAERS
22PalpitationsFAERS: 43
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
23TachycardiaFAERS: 43
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
24Visual ImpairmentFAERS: 42
Canada Vigilance: 1
Canada Vigilance
US FAERS
25Drug withdrawal syndromeFAERS: 41
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
26Weight decreasedFAERS: 40
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
27Toxicity to various agentsFAERS: 38US FAERS
28RhabdomyolysisFAERS: 3716841636CTD
US FAERS
29NervousnessFAERS: 36
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
30DysarthriaFAERS: 35
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
31PainFAERS: 35
Canada Vigilance: 4
18329221CTD
SIDER
Canada Vigilance
US FAERS
32Product substitution issueFAERS: 35
Canada Vigilance: 14
Canada Vigilance
US FAERS
33Depressed moodFAERS: 33
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
34Drug abuseFAERS: 32US FAERS
35PruritusFAERS: 32
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
36Product use in unapproved indicationFAERS: 31US FAERS
37RestlessnessFAERS: 31
Canada Vigilance: 4
Canada Vigilance
US FAERS
38AmnesiaFAERS: 30
Canada Vigilance: 5
10817523CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
39TinnitusFAERS: 29
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
40Wrong technique in product usage processFAERS: 29US FAERS
41HypersensitivityFAERS: 28SIDER
US FAERS
42SyncopeFAERS: 28SIDER
US FAERS
43Burning sensationFAERS: 27
Canada Vigilance: 2
Canada Vigilance
US FAERS
44ConstipationFAERS: 27
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
45Drug exposure during pregnancyFAERS: 27US FAERS
46Memory impairmentFAERS: 27
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
47Alanine Aminotransferase IncreasedFAERS: 26
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
48Cerebrovascular accidentFAERS: 26US FAERS
49EpilepsyFAERS: 26SIDER
US FAERS
50Abnormal weight gainFAERS: 25US FAERS
51Oropharyngeal painFAERS: 25
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
52SoporFAERS: 25US FAERS
53Adverse eventFAERS: 24US FAERS
54Chest PainFAERS: 24
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
SIDER
US FAERS
55Stevens-Johnson SyndromeFAERS: 2325811541CTD
OFFSIDES
SIDER
US FAERS
56DisorientationFAERS: 22
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
57Product use issueFAERS: 22US FAERS
58Serotonin SyndromeFAERS: 22SIDER
US FAERS
59DissociationFAERS: 21
Canada Vigilance: 2
Canada Vigilance
US FAERS
60Pulmonary EmbolismFAERS: 21
Canada Vigilance: 3
16841636CTD
SIDER
Canada Vigilance
US FAERS
61ChillsFAERS: 20
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
62No adverse eventFAERS: 20US FAERS
63PneumoniaFAERS: 20
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
64Aspartate Aminotransferase IncreasedFAERS: 19SIDER
US FAERS
65Gamma-Glutamyltransferase IncreasedFAERS: 19OFFSIDES
US FAERS
66Night sweatsFAERS: 19US FAERS
67Poor quality sleepFAERS: 19US FAERS
68Altered state of consciousnessFAERS: 18US FAERS
69AngioedemaFAERS: 18US FAERS
70Joint swellingFAERS: 18SIDER
US FAERS
71AkathisiaFAERS: 16
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
72Atrial FibrillationFAERS: 16US FAERS
73Deep Vein ThrombosisFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
74DysgeusiaFAERS: 16SIDER
US FAERS
75Mental status changesFAERS: 16US FAERS
76Personality ChangeFAERS: 16US FAERS
77Respiratory FailureFAERS: 16US FAERS
78Back PainFAERS: 15
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
79DeliriumFAERS: 15SIDER
US FAERS
80HypersomniaFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
81Musculoskeletal stiffnessFAERS: 15SIDER
US FAERS
82Product quality issueFAERS: 15US FAERS
83ThrombocytopeniaFAERS: 15SIDER
US FAERS
84jaundiceFAERS: 15SIDER
US FAERS
85Emotional distressFAERS: 14US FAERS
86Incorrect dose administeredFAERS: 14US FAERS
87Intentional self-injuryFAERS: 14US FAERS
88LethargyFAERS: 1418548827CTD
OFFSIDES
SIDER
US FAERS
89Maternal exposure during pregnancyFAERS: 14US FAERS
90Optic AtrophyFAERS: 14US FAERS
91ParanoiaFAERS: 14
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
92PriapismFAERS: 14US FAERS
93CD4 Lymphocytes DecreasedFAERS: 13US FAERS
94CryingFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
95Mood swingsFAERS: 13
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
96Sinus TachycardiaFAERS: 13US FAERS
97Temporal ArteritisFAERS: 13US FAERS
98VertigoFAERS: 13
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
99White blood cell count decreasedFAERS: 13US FAERS
100Drug ineffective for unapproved indicationFAERS: 12US FAERS
101HyperkinesiaFAERS: 12SIDER
US FAERS
102Medication ErrorFAERS: 12
Canada Vigilance: 3
Canada Vigilance
US FAERS
103SepsisFAERS: 12US FAERS
104Tardive DyskinesiaFAERS: 12US FAERS
105Therapeutic response unexpected with drug substitutionFAERS: 12US FAERS
106AlopeciaFAERS: 11
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
107Blood creatine phosphokinase increasedFAERS: 11OFFSIDES
US FAERS
108Drug toxicityFAERS: 11OFFSIDES
US FAERS
109HepatotoxicityFAERS: 11US FAERS
110Neuroleptic Malignant SyndromeFAERS: 11US FAERS
111PancreatitisFAERS: 11SIDER
US FAERS
112Therapeutic response unexpectedFAERS: 11US FAERS
113Abdominal discomfortFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
114AgeusiaFAERS: 10SIDER
US FAERS
115Angina PectorisFAERS: 10SIDER
US FAERS
116Diabetic KetoacidosisFAERS: 10US FAERS
117Drug prescribing errorFAERS: 10US FAERS
118Feeling jitteryFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
119HostilityFAERS: 10
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
120NeutropeniaFAERS: 10SIDER
US FAERS
121Prescribed overdoseFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
122Urinary IncontinenceFAERS: 10
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
123Urinary RetentionFAERS: 1020686159CTD
SIDER
US FAERS
124Wrong technique in drug usage processFAERS: 10US FAERS
125Basal cell carcinomaFAERS: 9US FAERS
126Cardiac ArrestFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
127Diabetes MellitusFAERS: 9SIDER
US FAERS
128Dry skinFAERS: 9OFFSIDES
SIDER
US FAERS
129HepatitisFAERS: 9SIDER
US FAERS
130HypotensionFAERS: 919332869CTD
SIDER
US FAERS
131Sudden deathFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
132TachyphreniaFAERS: 9US FAERS
133WheezingFAERS: 9US FAERS
134ApathyFAERS: 8OFFSIDES
SIDER
US FAERS
135BallismusFAERS: 8US FAERS
136Blood glucose increasedFAERS: 8US FAERS
137BradycardiaFAERS: 8OFFSIDES
SIDER
US FAERS
138DehydrationFAERS: 8OFFSIDES
SIDER
US FAERS
139Depressed Level of ConsciousnessFAERS: 8OFFSIDES
SIDER
US FAERS
140DiscomfortFAERS: 8
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
141Drug administration errorFAERS: 8OFFSIDES
US FAERS
142DysuriaFAERS: 8SIDER
US FAERS
143Euphoric moodFAERS: 8SIDER
US FAERS
144General physical health deteriorationFAERS: 8US FAERS
145Middle insomniaFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
146Negative thoughtsFAERS: 8US FAERS
147Peripheral swellingFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
148PregnancyFAERS: 8US FAERS
149Product physical issueFAERS: 8US FAERS
150Sleep ParalysisFAERS: 8US FAERS
151Systemic Inflammatory Response SyndromeFAERS: 8US FAERS
152ThirstFAERS: 8SIDER
US FAERS
153Abdominal PainFAERS: 7
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
154Accidental overdoseFAERS: 7US FAERS
155AgranulocytosisFAERS: 7SIDER
US FAERS
156Blood alkaline phosphatase increasedFAERS: 7US FAERS
157Blood lactate dehydrogenase increasedFAERS: 7US FAERS
158Dose calculation errorFAERS: 7US FAERS
159DrowningFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
160Drug dispensing errorFAERS: 7US FAERS
161DyspareuniaFAERS: 7US FAERS
162ErythemaFAERS: 7
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
163Eye painFAERS: 7SIDER
US FAERS
164Hypothermia neonatalFAERS: 7US FAERS
165InfluenzaFAERS: 7SIDER
US FAERS
166Intentional product misuseFAERS: 7US FAERS
167LeukopeniaFAERS: 7SIDER
US FAERS
168LymphomaFAERS: 7US FAERS
169Muscle RigidityFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
170Musculoskeletal PainFAERS: 7US FAERS
171Chest discomfortFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
172FlatulenceFAERS: 6
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
173FrustrationFAERS: 6US FAERS
174HomicideFAERS: 6US FAERS
175HyperreflexiaFAERS: 6OFFSIDES
SIDER
US FAERS
176Impaired driving abilityFAERS: 6US FAERS
177InflammationFAERS: 6US FAERS
178Lip swellingFAERS: 6US FAERS
179LymphadenopathyFAERS: 6SIDER
US FAERS
180Myocardial InfarctionFAERS: 6SIDER
US FAERS
181SchizophreniaFAERS: 6US FAERS
182ScreamingFAERS: 6US FAERS
183SomnambulismFAERS: 6US FAERS
184StillbirthFAERS: 6US FAERS
185StomatitisFAERS: 6SIDER
US FAERS
186Unresponsive to stimuliFAERS: 6US FAERS
187VasculitisFAERS: 6US FAERS
188Violence-related symptomFAERS: 6OFFSIDES
US FAERS
189treatment failureFAERS: 6US FAERS
190AbasiaFAERS: 5US FAERS
191Activation syndromeFAERS: 5US FAERS
192AnosmiaFAERS: 5US FAERS
193Blood albumin decreasedFAERS: 5OFFSIDES
US FAERS
194Blood potassium increasedFAERS: 5US FAERS
195BradykinesiaFAERS: 5US FAERS
196CholestasisFAERS: 5US FAERS
197Compulsive sexual behaviourFAERS: 5US FAERS
198Depression suicidalFAERS: 5US FAERS
199Disease recurrenceFAERS: 5US FAERS
200Drug DependenceFAERS: 5SIDER
US FAERS
201Drug dose omissionFAERS: 5US FAERS
202Drug screen positiveFAERS: 5US FAERS
203DyspepsiaFAERS: 5SIDER
US FAERS
204DystoniaFAERS: 512019672CTD
US FAERS
205FibromyalgiaFAERS: 5US FAERS
206GlaucomaFAERS: 5OFFSIDES
SIDER
US FAERS
207Hallucinations, mixedFAERS: 5US FAERS
208Head discomfortFAERS: 5US FAERS
209HungerFAERS: 5US FAERS
210Hypocoagulable stateFAERS: 5US FAERS
211Inappropriate affectFAERS: 5US FAERS
212Mouth swellingFAERS: 5US FAERS
213MyoclonusFAERS: 5SIDER
US FAERS
214Neonatal disorderFAERS: 5US FAERS
215Nerve injuryFAERS: 5US FAERS
216PoisoningFAERS: 5US FAERS
217PresyncopeFAERS: 5US FAERS
218Product solubility abnormalFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
219Product storage errorFAERS: 5US FAERS
220Pulmonary InfarctionFAERS: 5US FAERS
221Sinus bradycardiaFAERS: 5US FAERS
222Status EpilepticusFAERS: 5US FAERS
223Sweating feverFAERS: 5US FAERS
224TensionFAERS: 5SIDER
US FAERS
225Tongue blisteringFAERS: 5US FAERS
226Urinary tract infectionFAERS: 5SIDER
US FAERS
227UrticariaFAERS: 5SIDER
US FAERS
228Activities of daily living impairedFAERS: 4OFFSIDES
US FAERS
229Acute psychosisFAERS: 4US FAERS
230AnorgasmiaFAERS: 4US FAERS
231AsphyxiaFAERS: 4
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
232AtaxiaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
233Atrioventricular BlockFAERS: 4US FAERS
234BlindnessFAERS: 4US FAERS
235Blood glucose abnormalFAERS: 4US FAERS
236Blood triglycerides increasedFAERS: 4OFFSIDES
SIDER
US FAERS
237BradyphreniaFAERS: 4US FAERS
238ChoreoathetosisFAERS: 4US FAERS
239Circumstance or information capable of leading to medication errorFAERS: 4US FAERS
240Complex partial seizuresFAERS: 4US FAERS
241Drug effect incompleteFAERS: 4US FAERS
242Ear discomfortFAERS: 4US FAERS
243EcchymosisFAERS: 4US FAERS
244Emotional disorderFAERS: 4US FAERS
245EosinophiliaFAERS: 4SIDER
US FAERS
246GingivitisFAERS: 4US FAERS
247GoutFAERS: 4SIDER
US FAERS
248HypomaniaFAERS: 4
Canada Vigilance: 3
Canada Vigilance
US FAERS
249HypothyroidismFAERS: 4SIDER
US FAERS
250Inappropriate schedule of drug administrationFAERS: 4US FAERS
251Intentional product use issueFAERS: 4US FAERS
252Intrusive thoughtsFAERS: 4US FAERS
253Loose toothFAERS: 4US FAERS
254Lupus-like syndromeFAERS: 4US FAERS
255Mental impairmentFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
256Mycoplasma test positiveFAERS: 4US FAERS
257MyopathyFAERS: 4US FAERS
258Neck PainFAERS: 4
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
259Obsessive-Compulsive DisorderFAERS: 415491244CTD
US FAERS
260Oral mucosal erythemaFAERS: 4US FAERS
261PneumothoraxFAERS: 4OFFSIDES
SIDER
US FAERS
262Pre-EclampsiaFAERS: 4US FAERS
263Product taste abnormalFAERS: 4US FAERS
264RetchingFAERS: 4US FAERS
265Rheumatoid ArthritisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
266SwellingFAERS: 4US FAERS
267Therapeutic product ineffectiveFAERS: 4US FAERS
268Throat irritationFAERS: 4US FAERS
269Unevaluable eventFAERS: 4US FAERS
270Accidental drug intake by childFAERS: 3US FAERS
271Alcohol interactionFAERS: 3US FAERS
272AmphetaminesFAERS: 3US FAERS
273AnorexiaFAERS: 3OFFSIDES
SIDER
US FAERS
274AphasiaFAERS: 3SIDER
US FAERS
275ArthropathyFAERS: 3SIDER
US FAERS
276AsthmaFAERS: 3SIDER
US FAERS
277Bipolar DisorderFAERS: 312409687
20124786
CTD
US FAERS
278Blood creatinine increasedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
279Blood glucose decreasedFAERS: 3US FAERS
280Blood potassium decreasedFAERS: 3OFFSIDES
US FAERS
281Blood sodium decreasedFAERS: 3US FAERS
282BronchitisFAERS: 3SIDER
US FAERS
283Carpal Tunnel SyndromeFAERS: 3US FAERS
284CataractFAERS: 3OFFSIDES
US FAERS
285Chlamydia test positiveFAERS: 3US FAERS
286ColitisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
287DroolingFAERS: 3US FAERS
288Drug effect delayedFAERS: 3US FAERS
289Drug resistanceFAERS: 3US FAERS
290Drug screen false positiveFAERS: 3US FAERS
291EczemaFAERS: 3US FAERS
292Flat affectFAERS: 3SIDER
US FAERS
293Food AllergyFAERS: 3US FAERS
294Food cravingFAERS: 3US FAERS
295Foreign body sensation in eyesFAERS: 3US FAERS
296HyperacusisFAERS: 3SIDER
US FAERS
297HyperventilationFAERS: 3US FAERS
298Hypoaesthesia facialFAERS: 3US FAERS
299Impaired work abilityFAERS: 3US FAERS
300Initial insomniaFAERS: 3US FAERS
301Intentional misuseFAERS: 3US FAERS
302Joint Range of Motion DecreasedFAERS: 3US FAERS
303Lactose IntoleranceFAERS: 3US FAERS
304Leukocytoclastic vasculitisFAERS: 3US FAERS
305Loss of personal independence in daily activitiesFAERS: 3US FAERS
306Metabolic acidosisFAERS: 3US FAERS
307Multiple SclerosisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
308Multiple drug overdoseFAERS: 3OFFSIDES
US FAERS
309MydriasisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
310NasopharyngitisFAERS: 3US FAERS
311Neutrophil count decreasedFAERS: 3OFFSIDES
US FAERS
312NocturiaFAERS: 3US FAERS
313Panic DisorderFAERS: 3US FAERS
314PetechiaeFAERS: 3SIDER
US FAERS
315PhotophobiaFAERS: 3US FAERS
316Product availability issueFAERS: 3US FAERS
317Product counterfeitFAERS: 3US FAERS
318Pulmonary HypertensionFAERS: 3US FAERS
319QRS axis abnormalFAERS: 3OFFSIDES
US FAERS
320Sexual DysfunctionFAERS: 3US FAERS
321SinusitisFAERS: 3SIDER
US FAERS
322Slow speechFAERS: 3US FAERS
323SneezingFAERS: 3US FAERS
324StressFAERS: 3
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
325Therapy cessationFAERS: 3US FAERS
326ThrombophlebitisFAERS: 3OFFSIDES
US FAERS
327Tonic clonic movementsFAERS: 3US FAERS
328Visual disturbanceFAERS: 3OFFSIDES
US FAERS
329nervous system disorderFAERS: 3SIDER
US FAERS
330Accidental deathFAERS: 2US FAERS
331Acute kidney injuryFAERS: 2US FAERS
332Antiphospholipid antibodies positiveFAERS: 2US FAERS
333Aphthous StomatitisFAERS: 2OFFSIDES
SIDER
US FAERS
334AscitesFAERS: 2US FAERS
335BedriddenFAERS: 2US FAERS
336Blood chloride decreasedFAERS: 2US FAERS
337Blood cholesterol increasedFAERS: 2SIDER
US FAERS
338Blood prolactin increasedFAERS: 2US FAERS
339Bone painFAERS: 2
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
340Breast tendernessFAERS: 2US FAERS
341BursitisFAERS: 2OFFSIDES
SIDER
US FAERS
342Caustic injuryFAERS: 2US FAERS
343Cerebral InfarctionFAERS: 2US FAERS
344CheilitisFAERS: 2US FAERS
345Conversion disorderFAERS: 2US FAERS
346Cortisol decreasedFAERS: 2US FAERS
347CystitisFAERS: 2SIDER
US FAERS
348Cytolytic hepatitisFAERS: 2US FAERS
349DeafnessFAERS: 2SIDER
US FAERS
350Dental cariesFAERS: 2US FAERS
351DermatitisFAERS: 2SIDER
US FAERS
352Diabetes mellitus inadequate controlFAERS: 2OFFSIDES
US FAERS
353DisabilityFAERS: 2US FAERS
354Drug abuserFAERS: 2US FAERS
355Dysthymic DisorderFAERS: 2OFFSIDES
US FAERS
356Electroencephalogram abnormalFAERS: 2US FAERS
357Enamel anomalyFAERS: 2US FAERS
358Excessive masturbationFAERS: 2US FAERS
359ExcitabilityFAERS: 2US FAERS
360Eye InfectionFAERS: 2OFFSIDES
US FAERS
361Facial ParesisFAERS: 2US FAERS
362FormicationFAERS: 2US FAERS
363FractureFAERS: 2US FAERS
364Gastrointestinal toxicityFAERS: 2US FAERS
365GastrostomyFAERS: 2US FAERS
366HypophagiaFAERS: 2US FAERS
367HypoxiaFAERS: 2US FAERS
368IncoherentFAERS: 2OFFSIDES
US FAERS
369IncontinenceFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
370InfectionFAERS: 2SIDER
US FAERS
371Injury asphyxiationFAERS: 2US FAERS
372Intentional drug misuseFAERS: 2US FAERS
373Intercepted drug dispensing errorFAERS: 2US FAERS
374Liver scan abnormalFAERS: 2US FAERS
375Lymphocyte count decreasedFAERS: 2US FAERS
376Lymphocyte percentage decreasedFAERS: 2US FAERS
377LymphopeniaFAERS: 2US FAERS
378MalnutritionFAERS: 2SIDER
US FAERS
379MalocclusionFAERS: 2US FAERS
380Milk AllergyFAERS: 2US FAERS
381Muscle SpasticityFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
382Muscle tightnessFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
383MutismFAERS: 2US FAERS
384Ocular HypertensionFAERS: 2US FAERS
385Oral painFAERS: 2US FAERS
386Orthostatic hypertensionFAERS: 2SIDER
US FAERS
387OsteolysisFAERS: 2US FAERS
388Pain of skinFAERS: 2US FAERS
389PancytopeniaFAERS: 2
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
390Performance status decreasedFAERS: 2US FAERS
391Pharyngolaryngeal PainFAERS: 2US FAERS
392Physical assaultFAERS: 2US FAERS
393PleurothotonusFAERS: 2US FAERS
394Product dose omissionFAERS: 2US FAERS
395Product supply issueFAERS: 2US FAERS
396Protein total increasedFAERS: 2US FAERS
397PsoriasisFAERS: 2OFFSIDES
US FAERS
398Psychomotor skills impairedFAERS: 2US FAERS
399Psychotic symptomFAERS: 2US FAERS
400Pulmonary arterial hypertensionFAERS: 2US FAERS
401PurpuraFAERS: 2US FAERS
402QuadriplegiaFAERS: 2US FAERS
403Renal painFAERS: 2US FAERS
404Sedation complicationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
405Sinus ArrhythmiaFAERS: 2US FAERS
406StaringFAERS: 2US FAERS
407Supraventricular tachycardiaFAERS: 2US FAERS
408SynovitisFAERS: 2US FAERS
409Tension HeadacheFAERS: 2US FAERS
410Therapy non-responderFAERS: 2US FAERS
411Tongue bitingFAERS: 2US FAERS
412Transcription medication errorFAERS: 2US FAERS
413Wrong drug administeredFAERS: 2US FAERS
414muscle injuryFAERS: 2US FAERS
415Abdominal massFAERS: 1US FAERS
416Abnormal sleep-related eventFAERS: 1US FAERS
417AbscessFAERS: 1US FAERS
418Accidental exposureFAERS: 1US FAERS
419AcidosisFAERS: 1US FAERS
420AcneFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
421Acute myocardial infarctionFAERS: 1OFFSIDES
US FAERS
422Alcohol poisoningFAERS: 1US FAERS
423Allergic reaction to excipientFAERS: 1US FAERS
424Angle Closure GlaucomaFAERS: 1SIDER
US FAERS
425AnhedoniaFAERS: 1US FAERS
426Ankle FractureFAERS: 1US FAERS
427Anticholinergic SyndromeFAERS: 1US FAERS
428Antidepressant drug level above therapeuticFAERS: 1US FAERS
429Antidepressant drug level decreasedFAERS: 1US FAERS
430Antipsychotic drug level above therapeuticFAERS: 1US FAERS
431AnuriaFAERS: 1US FAERS
432AphagiaFAERS: 1OFFSIDES
US FAERS
433AppendicitisFAERS: 1US FAERS
434ArthritisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
435Arthropod biteFAERS: 1US FAERS
436AsthenopiaFAERS: 1US FAERS
437AtelectasisFAERS: 1OFFSIDES
US FAERS
438AuraFAERS: 1OFFSIDES
US FAERS
439Autoimmune thyroiditisFAERS: 1US FAERS
440AutomatismFAERS: 1OFFSIDES
US FAERS
441BelligerenceFAERS: 1US FAERS
442Bipolar I disorderFAERS: 1US FAERS
443Bladder painFAERS: 1SIDER
US FAERS
444BlepharospasmFAERS: 1US FAERS
445Blood creatine increasedFAERS: 1US FAERS
446Blood phosphorus increasedFAERS: 1US FAERS
447Blood sodium increasedFAERS: 1US FAERS
448Blood testosterone decreasedFAERS: 1US FAERS
449Blood urea increasedFAERS: 1US FAERS
450Blood urine presentFAERS: 1OFFSIDES
US FAERS
451Brain natriuretic peptide increasedFAERS: 1US FAERS
452Breast CystFAERS: 1US FAERS
453BronchiectasisFAERS: 1US FAERS
454CardiomegalyFAERS: 1SIDER
US FAERS
455CarditisFAERS: 1US FAERS
456Central nervous system function test abnormalFAERS: 1US FAERS
457Cerebral disorderFAERS: 1US FAERS
458Change in sustained attentionFAERS: 1US FAERS
459ChemotherapyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
460ChokingFAERS: 1US FAERS
461ChromaturiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
462Cleft PalateFAERS: 1US FAERS
463Compulsive shoppingFAERS: 1US FAERS
464Conduct DisorderFAERS: 1US FAERS
465Congenital choroid plexus cystFAERS: 1US FAERS
466Corneal InfectionFAERS: 1US FAERS
467CystFAERS: 1US FAERS
468Deafness NeurosensoryFAERS: 1US FAERS
469Death of companionFAERS: 1US FAERS
470DementiaFAERS: 1SIDER
US FAERS
471DependenceFAERS: 1SIDER
US FAERS
472Device computer issueFAERS: 1US FAERS
473DiplopiaFAERS: 1SIDER
US FAERS
474Disease complicationFAERS: 1US FAERS
475Dissociative disorderFAERS: 1US FAERS
476DiverticulitisFAERS: 1US FAERS
477Drug administered to patient of inappropriate ageFAERS: 1US FAERS
478Drug dispensed to wrong patientFAERS: 1US FAERS
479Drug exposure via breast milkFAERS: 1US FAERS
480DysgraphiaFAERS: 1US FAERS
481DysphasiaFAERS: 1US FAERS
482Economic problemFAERS: 1US FAERS
483Ectopic PregnancyFAERS: 1US FAERS
484Ejection Fraction DecreasedFAERS: 1US FAERS
485Electrocardiogram QT interval abnormalFAERS: 1US FAERS
486Electrocardiogram abnormalFAERS: 1US FAERS
487Electrocardiogram changeFAERS: 1US FAERS
488Elevated moodFAERS: 1US FAERS
489EmbolismFAERS: 1SIDER
US FAERS
490Enlarged uvulaFAERS: 1US FAERS
491EnthesopathyFAERS: 1US FAERS
492Eosinophil percentage increasedFAERS: 1US FAERS
493EpistaxisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
494Erectile dysfunctionFAERS: 1OFFSIDES
SIDER
US FAERS
495EructationFAERS: 1SIDER
US FAERS
496Expired product administeredFAERS: 1US FAERS
497Exposure during breast feedingFAERS: 1US FAERS
498Feeding tube complicationFAERS: 1US FAERS
499Feeling ColdFAERS: 1US FAERS
500Flank PainFAERS: 1US FAERS
501Flight of ideasFAERS: 1US FAERS
502FlushingFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
503FolliculitisFAERS: 1US FAERS
504Food PoisoningFAERS: 1US FAERS
505Free prostate-specific antigen positiveFAERS: 1US FAERS
506Gait inabilityFAERS: 1US FAERS
507Gastric mucosa erythemaFAERS: 1US FAERS
508GastritisFAERS: 1SIDER
US FAERS
509Gastrointestinal hypomotilityFAERS: 1US FAERS
510Gastrointestinal mucosal disorderFAERS: 1US FAERS
511GastroschisisFAERS: 1US FAERS
512General nutrition disorderFAERS: 1US FAERS
513Genital HerpesFAERS: 1US FAERS
514GlossoptosisFAERS: 1US FAERS
515Gluten sensitivityFAERS: 1US FAERS
516Grip strength decreasedFAERS: 1US FAERS
517Heat ExhaustionFAERS: 1US FAERS
518HemiplegiaFAERS: 1US FAERS
519HepatectomyFAERS: 1US FAERS
520Hepatic EncephalopathyFAERS: 1US FAERS
521Hepatic necrosisFAERS: 1US FAERS
522Hepatitis A antibody positiveFAERS: 1US FAERS
523Hepatitis B VirusFAERS: 1US FAERS
524High density lipoprotein increasedFAERS: 1US FAERS
525Histone antibody positiveFAERS: 1US FAERS
526HydrocephalusFAERS: 1US FAERS
527HydronephrosisFAERS: 1US FAERS
528Hyperosmolar stateFAERS: 1US FAERS
529HyperthyroidismFAERS: 1US FAERS
530HypervigilanceFAERS: 1US FAERS
531HypokinesiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
532HypopituitarismFAERS: 1US FAERS
533HyporeflexiaFAERS: 1US FAERS
534HypospadiasFAERS: 1US FAERS
535HypotrichosisFAERS: 1US FAERS
536Iatrogenic injuryFAERS: 1OFFSIDES
US FAERS
537Imminent abortionFAERS: 1US FAERS
538Inability to afford medicationFAERS: 1US FAERS
539Incorrect drug administration durationFAERS: 1US FAERS
540Incorrect product storageFAERS: 1US FAERS
541InfarctionFAERS: 1US FAERS
542Insulin ResistanceFAERS: 1OFFSIDES
US FAERS
543Intercepted drug prescribing errorFAERS: 1US FAERS
544Intestinal ObstructionFAERS: 1SIDER
US FAERS
545Intestinal PerforationFAERS: 1US FAERS
546Intestinal metastasisFAERS: 1US FAERS
547Investigation abnormalFAERS: 1US FAERS
548Jealous delusionFAERS: 1US FAERS
549Joint stiffnessFAERS: 1US FAERS
550LaryngitisFAERS: 1SIDER
US FAERS
551LeukocytosisFAERS: 1US FAERS
552Limb discomfortFAERS: 1US FAERS
553Lipids abnormalFAERS: 1US FAERS
554LipomaFAERS: 1US FAERS
555Lung consolidationFAERS: 1US FAERS
556LymphocytosisFAERS: 1SIDER
US FAERS
557Macular degenerationFAERS: 1US FAERS
558Manufacturing materials contaminationFAERS: 1US FAERS
559Markedly reduced dietary intakeFAERS: 1US FAERS
560Maternal exposure before pregnancyFAERS: 1US FAERS
561Mediastinal FibrosisFAERS: 1US FAERS
562MenorrhagiaFAERS: 1SIDER
US FAERS
563Metastases to stomachFAERS: 1US FAERS
564Micturition frequency decreasedFAERS: 1US FAERS
565Migraine with AuraFAERS: 1US FAERS
566Monocyte percentage increasedFAERS: 1US FAERS
567Multiple MyelomaFAERS: 1OFFSIDES
US FAERS
568Muscular DystrophyFAERS: 1US FAERS
569Musculoskeletal discomfortFAERS: 1SIDER
US FAERS
570MyositisFAERS: 1SIDER
US FAERS
571NarcolepsyFAERS: 1US FAERS
572Neonatal respiratory failureFAERS: 1US FAERS
573NeuralgiaFAERS: 1OFFSIDES
US FAERS
574Nonspecific reactionFAERS: 1US FAERS
575Nuchal RigidityFAERS: 1OFFSIDES
SIDER
US FAERS
576Occupational exposure to productFAERS: 1US FAERS
577Ocular icterusFAERS: 1US FAERS
578Oral mucosal exfoliationFAERS: 1US FAERS
579Oropharyngeal swellingFAERS: 1US FAERS
580OsteoporosisFAERS: 1US FAERS
581ParamnesiaFAERS: 1US FAERS
582ParasomniaFAERS: 1US FAERS
583PemphigusFAERS: 1US FAERS
584Penile swellingFAERS: 1US FAERS
585Peptic UlcerFAERS: 1US FAERS
586Pericardial effusionFAERS: 1US FAERS
587PericarditisFAERS: 1US FAERS
588Physical disabilityFAERS: 1US FAERS
589Pituitary enlargementFAERS: 1US FAERS
590PlasmacytomaFAERS: 1US FAERS
591PneumonitisFAERS: 1US FAERS
592PolyarthritisFAERS: 1US FAERS
593PolydactylyFAERS: 1US FAERS
594PolydipsiaFAERS: 1US FAERS
595PolymyalgiaFAERS: 1US FAERS
596PolyneuropathyFAERS: 1OFFSIDES
US FAERS
597PolyserositisFAERS: 1US FAERS
598Poor sucking reflexFAERS: 1US FAERS
599Pre-existing condition improvedFAERS: 1US FAERS
600Pressure of speechFAERS: 1US FAERS
601Product blister packaging issueFAERS: 1US FAERS
602Product contaminationFAERS: 1US FAERS
603Product difficult to swallowFAERS: 1US FAERS
604Product label issueFAERS: 1US FAERS
605Product packaging issueFAERS: 1US FAERS
606Product prescribing errorFAERS: 1US FAERS
607Product quality control issueFAERS: 1US FAERS
608Product size issueFAERS: 1US FAERS
609Productive CoughFAERS: 1US FAERS
610Psychiatric symptomFAERS: 1US FAERS
611Pulmonary FibrosisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
612Pulmonary artery thrombosisFAERS: 1US FAERS
613Pulmonary congestionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
614Pulmonary toxicityFAERS: 1US FAERS
615Quality of life decreasedFAERS: 1US FAERS
616RalesFAERS: 1US FAERS
617Reaction to drug excipientsFAERS: 1US FAERS
618Renal cystFAERS: 1US FAERS
619Renal tubular necrosisFAERS: 1US FAERS
620Respiratory DepressionFAERS: 1US FAERS
621Respiratory arrestFAERS: 1US FAERS
622Respiratory distressFAERS: 1US FAERS
623Rheumatic disorderFAERS: 1US FAERS
624Right Ventricular HypertrophyFAERS: 1US FAERS
625RosaceaFAERS: 1US FAERS
626SarcoidosisFAERS: 1US FAERS
627Scan abdomen abnormalFAERS: 1US FAERS
628Sexual inhibitionFAERS: 1US FAERS
629Sinoatrial BlockFAERS: 1US FAERS
630Sjogren's SyndromeFAERS: 1US FAERS
631Skeletal survey abnormalFAERS: 1US FAERS
632Skin lacerationFAERS: 1OFFSIDES
US FAERS
633Skin lesionFAERS: 1US FAERS
634SluggishnessFAERS: 1US FAERS
635SmokerFAERS: 1US FAERS
636SunburnFAERS: 1US FAERS
637Superior Vena Cava SyndromeFAERS: 1US FAERS
638Temperature intoleranceFAERS: 1US FAERS
639Therapeutic product effective for unapproved indicationFAERS: 1US FAERS
640Therapy changeFAERS: 1US FAERS
641Therapy regimen changedFAERS: 1US FAERS
642ThrombosisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
643Tooth ErosionFAERS: 1US FAERS
644Tooth ExtractionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
645TorticollisFAERS: 1US FAERS
646Toxic Epidermal NecrolysisFAERS: 1SIDER
US FAERS
647Toxicologic test abnormalFAERS: 1US FAERS
648Transaminases increasedFAERS: 1OFFSIDES
US FAERS
649Trisomy 21FAERS: 1US FAERS
650Urinary Tract PainFAERS: 1US FAERS
651Urine ketone body presentFAERS: 1US FAERS
652Urine osmolarity increasedFAERS: 1US FAERS
653Venous InsufficiencyFAERS: 1US FAERS
654Venous ThrombosisFAERS: 1US FAERS
655Venous thrombosis limbFAERS: 1US FAERS
656Ventricular FibrillationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
657Ventricular arrhythmiaFAERS: 1SIDER
US FAERS
658Vitreous DetachmentFAERS: 1US FAERS
659Vocal Cord DysfunctionFAERS: 1US FAERS
660White blood cell count abnormalFAERS: 1US FAERS
661XanthomaFAERS: 1US FAERS
662Abdominal AbscessOFFSIDES
663Abdominal tendernessOFFSIDES
664Abnormal ejaculationSIDER
665Acid refluxOFFSIDES
666AcromegalyOFFSIDES
667Acute Coronary SyndromeSIDER
668Acute bronchitisOFFSIDES
669Acute sinusitisOFFSIDES
670AdenomaOFFSIDES
671Adrenal atrophyOFFSIDES
672Akathisia, Drug-Induced16569791
20124786
CTD
673AmblyopiaSIDER
674Amphetamine-Related Disorders16096515
18329221
CTD
675Anal polypOFFSIDES
676Angular cheilitisCanada Vigilance: 1Canada Vigilance
677AnhidrosisOFFSIDES
678AnisocytosisOFFSIDES
679Application site erythemaOFFSIDES
680Application site pruritusOFFSIDES
681Arteriovenous fistula occlusionOFFSIDES
682Arteriovenous graft thrombosisOFFSIDES
683Aspiration PneumoniaOFFSIDES
684Atrial arrhythmiaSIDER
685Atrial tachycardiaOFFSIDES
686Atrial thrombosisOFFSIDES
687Atrophic vulvovaginitisOFFSIDES
688Autistic Disorder16648008CTD
689BK virus infectionOFFSIDES
690Biliary dilatationOFFSIDES
691Bilirubin conjugated increasedOFFSIDES
692Biopsy breast abnormalOFFSIDES
693Biopsy liver abnormalOFFSIDES
694Biopsy lymph gland abnormalOFFSIDES
695BlepharitisSIDER
696Blood 1,25-dihydroxycholecalciferol decreasedOFFSIDES
697Blood acid phosphatase increasedSIDER
698Blood and lymphatic system disordersSIDER
699Blood cholesterolOFFSIDES
700Blood cholinesterase decreasedOFFSIDES
701Blood sodiumOFFSIDES
702Blood thyroid stimulating hormoneOFFSIDES
703Body TemperatureOFFSIDES
704Bone density decreasedOFFSIDES
705Bone lesionOFFSIDES
706Bone marrow depressionSIDER
707Borderline Personality DisorderOFFSIDES
708Breast FeedingSIDER
709Breast engorgementSIDER
710Breast hyperplasiaOFFSIDES
711BronchopneumoniaOFFSIDES
712BruxismCanada Vigilance: 1Canada Vigilance
OFFSIDES
713Cardioactive drug levelOFFSIDES
714Catalepsy9498732CTD
715CatatoniaOFFSIDES
716CausalgiaOFFSIDES
717CellulitisOFFSIDES
SIDER
718Central nervous system lesionOFFSIDES
719Cerebral aspergillosisOFFSIDES
720Cerebral atrophyOFFSIDES
721Cervicobrachial syndromeOFFSIDES
722Chemical and Drug Induced Liver Injury15930079CTD
723CholangiolitisOFFSIDES
724CholecystitisOFFSIDES
SIDER
725Chorea15732128CTD
726Chronic Obstructive Airway DiseaseOFFSIDES
727Clostridium difficile colitisOFFSIDES
728Cocaine-Related Disorders12487943CTD
729ConfabulationOFFSIDES
730Congenital hypertrichosisOFFSIDES
731ConjunctivitisSIDER
732Corneal abscessOFFSIDES
733Cubital Tunnel SyndromeOFFSIDES
734CystoceleOFFSIDES
735Dental prosthesis placementOFFSIDES
736Depressive disorder

View details

CTD
737Device related infectionOFFSIDES
738DiabetesOFFSIDES
739Diabetic NephropathyOFFSIDES
740DiarrheaOFFSIDES
741Disease ProgressionOFFSIDES
742Disturbance in sexual arousalSIDER
743DiuresisSIDER
744DrowsinessSIDER
745Drug ToleranceSIDER
746Drug administered at inappropriate siteOFFSIDES
747Drug seeking behaviorSIDER
748Dyskinesia, Drug-Induced

View details

CTD
749Eating disorder symptomOFFSIDES
750Electrocardiogram ST segment abnormalOFFSIDES
751EndocarditisOFFSIDES
752Endometrial hypertrophyOFFSIDES
753EndophthalmitisOFFSIDES
754Enlargement abdomenSIDER
755EnteritisOFFSIDES
756Enterococcal infectionOFFSIDES
757Eosinophilic myocarditisOFFSIDES
758Erosive gastritisOFFSIDES
759Erythema MultiformeSIDER
760Esophageal StenosisOFFSIDES
761Failure to ThriveOFFSIDES
762Fatty LiverOFFSIDES
763Feeling of body temperature changeCanada Vigilance: 1Canada Vigilance
764Femoral pulse increasedCanada Vigilance: 1Canada Vigilance
765Foreign body in respiratory tractCanada Vigilance: 1Canada Vigilance
766Full blood count abnormalCanada Vigilance: 1Canada Vigilance
767Gait Disorders, Neurologic12409687CTD
768Galactorrhea-Hyperprolactinemia15105766CTD
769GamblingOFFSIDES
770GastroenteritisOFFSIDES
SIDER
771Gastrointestinal PainSIDER
772Gastrointestinal infectionOFFSIDES
773GlossitisSIDER
774Graft infectionOFFSIDES
775Gynecomastia15105766CTD
776Heart sounds abnormalOFFSIDES
777HemiparesisOFFSIDES
778Hepatic Insufficiency28623179CTD
779Hepatitis COFFSIDES
780Hyponatremia16997047CTD
781Infusion site mobility decreasedOFFSIDES
782Intention tremorOFFSIDES
783Intervertebral disc disorderOFFSIDES
784KeratitisSIDER
785KeratoconjunctivitisSIDER
786Lacrimal structural disorderSIDER
787Large intestine perforationOFFSIDES
788LeukoplakiaOFFSIDES
789LeukorrheaSIDER
790Limb operationOFFSIDES
791Liver Cirrhosis, Experimental28623179CTD
792Liver Failure, Acute16797245CTD
793MacrocytosisOFFSIDES
794Macular fibrosisCanada Vigilance: 1Canada Vigilance
795Manic psychosisSIDER
796MastectomyOFFSIDES
797Mental disorders16856516CTD
798MetaplasiaOFFSIDES
799MetrorrhagiaSIDER
800MiliariaCanada Vigilance: 1Canada Vigilance
801Mood Disorders8690829CTD
802Muscle relaxant therapySIDER
803Muscle strainOFFSIDES
804Musculoskeletal chest painOFFSIDES
805Neck stiffnessSIDER
806NephrolithiasisSIDER
807NystagmusSIDER
808Oral candidiasisSIDER
809Oropharyngeal discomfortSIDER
810OsteopeniaOFFSIDES
811Otitis MediaSIDER
812Oxygen saturation abnormalOFFSIDES
813Paranoid reactionSIDER
814Paresthesia12530413CTD
815Parkinson Disease10496290
20686159
CTD
816Partial transitory deafnessSIDER
817Pelvic prolapseOFFSIDES
818PeritonitisOFFSIDES
819PharyngitisSIDER
820PhlebitisSIDER
821PoikilocytosisOFFSIDES
822Polysubstance abuseOFFSIDES
823PolyuriaSIDER
824Post procedural bile leakOFFSIDES
825Postmenopausal bleedingOFFSIDES
826Protein total decreasedOFFSIDES
827Psychomotor Agitation12409687CTD
828Psychomotor Disorders15816785CTD
829Pulmonary thrombosisOFFSIDES
830Pustular psoriasisOFFSIDES
831PyelonephritisOFFSIDES
832Rectal ProlapseOFFSIDES
833Reflux gastritisOFFSIDES
834Retinal vascular thrombosisOFFSIDES
835Retrosternal painSIDER
836RhinitisSIDER
837RhonchiOFFSIDES
838Secretion dischargeOFFSIDES
839Septic ShockOFFSIDES
840SeromaOFFSIDES
841ShockSIDER
842Sinus headacheOFFSIDES
843Skin IndurationOFFSIDES
844Skin UlcerSIDER
845Skin hypertrophyOFFSIDES
SIDER
846Sleep Apnea Syndromes16625567CTD
847Sleep Initiation and Maintenance Disorders12409687CTD
848Sleep disorder due to general medical condition, insomnia typeCanada Vigilance: 1Canada Vigilance
849Spinal cord abscessCanada Vigilance: 1Canada Vigilance
850StuporCanada Vigilance: 2Canada Vigilance
SIDER
851Subcutaneous AbscessOFFSIDES
852Substance Withdrawal Syndrome18329221CTD
853Sudden Cardiac DeathOFFSIDES
854SweatingSIDER
855TenosynovitisSIDER
856Therapeutic product effect variableCanada Vigilance: 1Canada Vigilance
857Therapeutic response changedCanada Vigilance: 2Canada Vigilance
858ThromboembolismSIDER
859Thrombosis in deviceOFFSIDES
860Tolerance developmentSIDER
861Tongue discomfortCanada Vigilance: 1Canada Vigilance
862Tongue erythemaCanada Vigilance: 1Canada Vigilance
863TracheobronchitisOFFSIDES
864Ulcerative stomatitisSIDER
865UlcerSIDER
866Upper respiratory tract inflammationOFFSIDES
867Ureteral stent insertionOFFSIDES
868Urethritis noninfectiveSIDER
869UrethritisSIDER
870Urine output increasedSIDER
871Vaginal DischargeSIDER
872Vaginal ProlapseOFFSIDES
873Ventricular bigeminySIDER
874Walking aid userOFFSIDES
875Weight Gain12668379
18548827
CTD
876Wound dehiscenceOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.